The antibiotic susceptibility pattern of gas gangrene-forming Clostridium spp. clinical isolates from South-Eastern Hungary

References

• Hatheway CL. Toxigenic clostridia. Clin Microbiol Rev. 1990;3:66–98.
   PubMed Web of Science ®Google Scholar
• Chong E, Winikoff B, Charles D, et al. Vaginal and rectal Clostridium sordellii and Clostridium perfringens presence among women in the United States. Obstet Gynecol. 2016;127:360–368.
   PubMed Web of Science ®Google Scholar
• Granum PE. Clostridium perfringens toxins involved in food poisoning. Int J Food Microbiol. 1990;10:101–112.
   PubMed Web of Science ®Google Scholar
• Grass JE, Gould LH, Mahon BE. Epidemiology of foodborne disease outbreaks caused by Clostridium perfringens, United States, 1998-2010. Foodborne Pathog Dis. 2013;10:131–136.
   PubMed Web of Science ®Google Scholar
• Bos J, Smitthee L, McClane B, et al. Fatal necrotizing colitits following a foodborne outbreak of enterotoxigenic Clostridium perfringens type A infection. Clin Infect Dis. 2005;83:78–83.
   Google Scholar
• Debata NK, Chander Y, Singh L, et al. Investigation of a case of clostridial myonecrosis. Med J Armed Forces India. 1998;54:55–56.
   PubMedGoogle Scholar
• Guedira G, Taright N, Blin H, et al. Clostridium perfringens panophthalmitis and orbital cellulitis: a case report. BMC Ophthalmol. 2018;18:88.
   PubMed Web of Science ®Google Scholar
• Sarvari KP, Vasas B, Kiss I, et al. Fatal Clostridium perfringens sepsis due to emphysematous gastritis and literature review. Anaerobe. 2016;40:31–34.
   PubMed Web of Science ®Google Scholar
• Kimura AC, Higa JI, Levin RM, et al. Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users. Clin Infect Dis. 2004;38:e87–91.
   PubMed Web of Science ®Google Scholar
• Tsokos M, Schalinski S, Paulsen F, et al. Pathology of fatal traumatic and nontraumatic clostridial gas gangrene: a histopathological, immunohistological and ultrastructural study of six autopsy cases. Int J Legal Med. 2008;122:35–41.
   PubMed Web of Science ®Google Scholar
• Ho CS, Bhatnagar J, Cohen AL, et al. Undiagnosed cases of fatal Clostridium-associated toxic shock in Californian women of childbearing age. Am J Obstet Gynecol. 2009;201:e1–e7.
   PubMed Web of Science ®Google Scholar
• Aldape MJ, Bryant AE, Stevens DL. Clostridium sordellii infection: epidemiology, clinical findings and current perspectives on diagnosis and treatment. Clin Infect Dis. 2006;43:1436–1446.
   PubMed Web of Science ®Google Scholar
• Gredlein CM, Silvermann ML, Downey MS. Polymicrobial septic arthritis due to Clostridium species: case report and review. J Clin Pathol. 2000;53:709–712.
   PubMedGoogle Scholar
• Chaudhry R, Verma N, Bahadur T, et al. Clostridium sordellii as a cause of constrictive pericarditis with pyopericardium and tamponade. J Clin Microbiol. 2011;49:3700–3702.
   PubMed Web of Science ®Google Scholar
• Harris C, Geffen J, Rizg K, et al. A rare report of infectious emphysematous aortitis secondary to Clostridium septicum without prior vascular intervention. Case Rep Vasc Med. 2017;2017:4984325.
   PubMedGoogle Scholar
• Macha K, Giede-Jeppe A, Lücking H, et al. Ischaemic stroke and Clostridium septicum sepsis and meningitis in a patient with occult colon carcinoma – a case report and review of the literature. BMC Neurol. 2016;16:239.
   PubMed Web of Science ®Google Scholar
• Chew SSB, Lubowski DZ. Clostridium septicum and malignancy. ANZ J Surg. 2001;71:647–649.
   PubMed Web of Science ®Google Scholar
• Edagiz S, Lagace-Wiens P, Embil J, et al. Empyema caused by Clostridium bifermentans: a case report. Can J Infect Dis Med. 2015;26:105–107.
   PubMed Web of Science ®Google Scholar
• Nagy E, Urbán E, Nord CE. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience. Clin Microbiol Infect. 2011;17:371–379.
   PubMed Web of Science ®Google Scholar
• Sárvári KP, Sóki J, Kristóf K, et al. Molecular characterization of Multidrug Resistant Bacteroides isolates from Hungarian clinical samples. J Glob Antimicrob Resist. 2018;13:65–69.
   PubMed Web of Science ®Google Scholar
• Sydenham TV, Soki J, Hasman H, et al. Identification of antimicrobial resistance genes in multidrug-resistant clinical Bacteroides fragilis isolates by whole genome shotgun sequencing. Anaerobe. 2015;31:59–64.
   PubMed Web of Science ®Google Scholar
• Jousimies-Sommer H, Summanen P, Citron DM, et al. Wadsworth KTL anaerobic bacteriology manual. 6th ed. Belmont (CA): Star Publishing Company; 2002.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 23^rd informational supplement. CLSI document M100-S23. Wayne (PA): CLSI; 2013.
   Google Scholar
• European Committee on Antimicrobial Susceptibility Testing (EUCAST). Clinical breakpoints. Gram-positive anaerobes. p67 v. 8. 1. 2018
   Google Scholar
• Tigecycline: the US FDA susceptibility breakpoint to tigecycline for anaerobes is set at 4 mg/L. FDA Approved Drug Products Label for TYGACIL, NDA no. 021821 (approved on 23/05/2013). US FDA; 2013 [last accessed 2013 Jul 13]. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021821s037lbl.pdf
   Google Scholar
• Jeverica S, Kolenc U, Mueller-Premru M, et al. Evaluation of the routine antimicrobial susceptibility testing results of clinically significant anaerobic bacteria in a Slovenian tertiary-care hospital in 2015. Anaerobe. 2017;47:64–69.
   PubMed Web of Science ®Google Scholar
• Wang FD, Liao CH, Lin YT, et al. Trends in the susceptibility of commonly encountered clinically significant anaerobes and susceptibilities of blood isolates of anaerobes to 16 antimicrobial agents, including fidaxomicin and rifaximin, 2008–2012, northern Taiwan. Eur J Clin Microbiol Infect Dis. 2014;33:2041–2052.
   PubMed Web of Science ®Google Scholar
• Marchand-Austin A, Pawte P, Toye B, et al. Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011. Anaerobe. 2014;28:120–125.
   PubMed Web of Science ®Google Scholar